Article · 19 Jun 2026
Conference abstract
Artesunate/amodiaquine-induced acute extrapyramidal reactions in children and younger adults: Case series assessment
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction & Aim: Several studies conducted in African countries reported the artesunate and amodiaquine (AS/AQ) tablet as a safe and well-tolerated anti-malarial drug in children and younger adults. The Eritrean Pharmacovigilance Centre, however, received 43 acute extrapyramidal reactions associated with the AS/AQ tablet. The aim of this case series assessment was to assess the causal relationship between the AS/AQ and extrapyramidal reactions in children and younger adults and to investigate the factor(s) predisposing to the adverse drug reactions. Methods: The causal relationship of all the cases was first assessed individually using the Naranjo Probability Scale and then subjected to a case series assessment using Austin Bradfordâ??Hill criteria. Results: A total of 43 acute extrapyramidal reactions associated with the AS/AQ tablet were reported between 2012 and 16 November, 2015 to the Eritrean Pharmacovigilance Centre. The causality was found to be probable or highly probable for 33 (76.7%) of the cases and the rest (10; 23.3%) of the cases had a possible causal association. The extrapyramidal reactions had more or less similar clinical features in most of the cases and were characterized by abnormal involuntary contractions of muscles. The median age and body weight of the cases were 15 years and 40 kg, respectively, and 70% of them were males. 90.7% of the reactions manifested in children and younger adults (aged 26 years). In most of the cases, reactions manifested in the third day from the start of treatment and 88.3% of cases were hospitalized. Conclusion: The causal relationship between the AS/AQ tablet and extrapyramidal reactions in children and younger adults were found to be apparent and possibly owing to dose accumulation or an overdose of amodiaquine and/or genetic polymorphism.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmacovigilance.
Article · 19 Jun 2026
Strengthening Healthcare Outcomes Through Effective Drug Safety Practices
Article · 19 Jun 2026
Expanding Patient Care Through Clinical Pharmacy Services in Modern Healthcare
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacovigilance
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mulugeta Russom”
- BylineArticles whose byline prints “Dawit Tesfai”
- BylineArticles whose byline prints “Semere Gebregiorgis”
- BylineArticles whose byline prints “Abdulmumini Usman”
- BylineArticles whose byline prints “Selam Mihreteab”
- BylineArticles whose byline prints “Iyassu Bahta”
- BylineArticles whose byline prints “Elsa Mekonnen”
- BylineArticles whose byline prints “Selamawit Ghebrehiwet”
